Duey Marc
Insider CIK 1925150 · APRE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2026-06-16 | 2026-06-17 | 12,555 | — | $0 | 12,555 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2026-06-16 | 2026-06-17 | 3,135 | — | $0 | 259,290 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2025-12-10 | 2025-12-11 | 21,459 | — | $0 | 21,459 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2025-12-10 | 2025-12-11 | 21,459 | $1.17 | $25.1K | 256,155 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 4,185 | — | $0 | 4,185 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2025-06-05 | 2025-06-09 | 1,045 | — | $0 | 234,696 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-25 | 6,462 | $4.58 | $29.6K | 233,651 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-10-16 | 2024-10-17 | 30,000 | $4.39 | $131.7K | 240,113 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-10-14 | 2024-10-16 | 190 | $2.58 | $490 | 210,113 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 4,185 | — | $0 | 4,185 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2024-06-20 | 2024-06-21 | 1,045 | — | $0 | 209,923 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2023-08-23 | 2023-08-24 | 2,000 | — | $0 | 2,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2023-08-23 | 2023-08-24 | 500 | — | $0 | 208,878 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2022-08-23 | 2023-08-24 | 1,161 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2022-08-23 | 2023-08-24 | 400,969 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2022-08-23 | 2023-08-24 | 4,009,690 | — | $0 | 4,167,589 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2022-08-23 | 2023-08-24 | 11,610 | — | $0 | 602 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-07-28 | 2022-08-01 | 29,575 | — | $0 | 29,575 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-07-28 | 2022-08-01 | 5,995 | — | $0 | 157,899 | SEC↗ |